NEURONES (NRO.PA) Stock Fundamental Analysis
Europe - Euronext Paris - EPA:NRO - FR0004050250 - Common Stock
40.15 EUR
-0.8 (-1.95%)
We assign a fundamental rating of 6 out of 10 to NRO. NRO was compared to 76 industry peers in the IT Services industry. NRO has an excellent financial health rating, but there are some minor concerns on its profitability. NRO is not valued too expensively and it also shows a decent growth rate.
1. Profitability
1.1 Basic Checks
- In the past year NRO was profitable.
- In the past year NRO had a positive cash flow from operations.
- NRO had positive earnings in each of the past 5 years.
- In the past 5 years NRO always reported a positive cash flow from operatings.
1.2 Ratios
- NRO has a better Return On Assets (7.06%) than 71.05% of its industry peers.
- NRO has a Return On Equity (13.65%) which is in line with its industry peers.
- The Return On Invested Capital of NRO (11.38%) is better than 71.05% of its industry peers.
- The Average Return On Invested Capital over the past 3 years for NRO is significantly below the industry average of 25.98%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.06% | ||
| ROE | 13.65% | ||
| ROIC | 11.38% |
ROA(3y)7.25%
ROA(5y)6.8%
ROE(3y)13.74%
ROE(5y)12.58%
ROIC(3y)12.21%
ROIC(5y)11.57%
1.3 Margins
- Looking at the Profit Margin, with a value of 6.09%, NRO is in the better half of the industry, outperforming 67.11% of the companies in the same industry.
- In the last couple of years the Profit Margin of NRO has remained more or less at the same level.
- NRO has a Operating Margin of 8.90%. This is in the better half of the industry: NRO outperforms 67.11% of its industry peers.
- In the last couple of years the Operating Margin of NRO has remained more or less at the same level.
- Looking at the Gross Margin, with a value of 99.93%, NRO belongs to the top of the industry, outperforming 96.05% of the companies in the same industry.
- NRO's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 8.9% | ||
| PM (TTM) | 6.09% | ||
| GM | 99.93% |
OM growth 3Y-3.33%
OM growth 5Y-0.03%
PM growth 3Y-0.09%
PM growth 5Y1.44%
GM growth 3Y0%
GM growth 5Y0%
2. Health
2.1 Basic Checks
- NRO has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
- Compared to 1 year ago, NRO has about the same amount of shares outstanding.
- NRO has about the same amout of shares outstanding than it did 5 years ago.
- NRO has a better debt/assets ratio than last year.
2.2 Solvency
- An Altman-Z score of 4.44 indicates that NRO is not in any danger for bankruptcy at the moment.
- NRO has a better Altman-Z score (4.44) than 85.53% of its industry peers.
- The Debt to FCF ratio of NRO is 0.57, which is an excellent value as it means it would take NRO, only 0.57 years of fcf income to pay off all of its debts.
- The Debt to FCF ratio of NRO (0.57) is better than 90.79% of its industry peers.
- NRO has a Debt/Equity ratio of 0.08. This is a healthy value indicating a solid balance between debt and equity.
- NRO has a better Debt to Equity ratio (0.08) than 85.53% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.08 | ||
| Debt/FCF | 0.57 | ||
| Altman-Z | 4.44 |
ROIC/WACC0.78
WACC14.67%
2.3 Liquidity
- NRO has a Current Ratio of 2.31. This indicates that NRO is financially healthy and has no problem in meeting its short term obligations.
- NRO has a Current ratio of 2.31. This is amongst the best in the industry. NRO outperforms 90.79% of its industry peers.
- NRO has a Quick Ratio of 2.31. This indicates that NRO is financially healthy and has no problem in meeting its short term obligations.
- With an excellent Quick ratio value of 2.31, NRO belongs to the best of the industry, outperforming 92.11% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.31 | ||
| Quick Ratio | 2.31 |
3. Growth
3.1 Past
- The Earnings Per Share has been growing slightly by 4.44% over the past year.
- NRO shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 11.23% yearly.
- NRO shows a small growth in Revenue. In the last year, the Revenue has grown by 7.39%.
- Measured over the past years, NRO shows a quite strong growth in Revenue. The Revenue has been growing by 9.70% on average per year.
EPS 1Y (TTM)4.44%
EPS 3Y11.55%
EPS 5Y11.23%
EPS Q2Q%-7.43%
Revenue 1Y (TTM)7.39%
Revenue growth 3Y11.8%
Revenue growth 5Y9.7%
Sales Q2Q%5.42%
3.2 Future
- NRO is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 8.04% yearly.
- NRO is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.57% yearly.
EPS Next Y0%
EPS Next 2Y4.65%
EPS Next 3Y8.74%
EPS Next 5Y8.04%
Revenue Next Year6.74%
Revenue Next 2Y6.12%
Revenue Next 3Y6.07%
Revenue Next 5Y5.57%
3.3 Evolution
- The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
- The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
- NRO is valuated rather expensively with a Price/Earnings ratio of 19.30.
- The rest of the industry has a similar Price/Earnings ratio as NRO.
- When comparing the Price/Earnings ratio of NRO to the average of the S&P500 Index (26.94), we can say NRO is valued slightly cheaper.
- NRO is valuated rather expensively with a Price/Forward Earnings ratio of 17.28.
- NRO's Price/Forward Earnings is on the same level as the industry average.
- NRO's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 23.94.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 19.3 | ||
| Fwd PE | 17.28 |
4.2 Price Multiples
- Based on the Enterprise Value to EBITDA ratio, NRO is valued a bit cheaper than the industry average as 77.63% of the companies are valued more expensively.
- 60.53% of the companies in the same industry are more expensive than NRO, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 13.51 | ||
| EV/EBITDA | 5.52 |
4.3 Compensation for Growth
- NRO has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)1.72
EPS Next 2Y4.65%
EPS Next 3Y8.74%
5. Dividend
5.1 Amount
- NRO has a Yearly Dividend Yield of 3.08%. Purely for dividend investing, there may be better candidates out there.
- NRO's Dividend Yield is a higher than the industry average which is at 2.10.
- NRO's Dividend Yield is rather good when compared to the S&P500 average which is at 1.83.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.08% |
5.2 History
- On average, the dividend of NRO grows each year by 82.05%, which is quite nice.
Dividend Growth(5Y)82.05%
Div Incr Years3
Div Non Decr Years3
5.3 Sustainability
- NRO pays out 57.47% of its income as dividend. This is a bit on the high side, but may be sustainable.
- NRO's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP57.47%
EPS Next 2Y4.65%
EPS Next 3Y8.74%
EPA:NRO (1/21/2026, 5:28:56 PM)
40.15
-0.8 (-1.95%)
Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)11-05 2025-11-05
Earnings (Next)02-11 2026-02-11
Inst Owners12.82%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap976.85M
Revenue(TTM)832.18M
Net Income(TTM)50.68M
Analysts84
Price Target53.04 (32.1%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.08% |
Yearly Dividend1.2
Dividend Growth(5Y)82.05%
DP57.47%
Div Incr Years3
Div Non Decr Years3
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)5%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.47%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 19.3 | ||
| Fwd PE | 17.28 | ||
| P/S | 1.17 | ||
| P/FCF | 13.51 | ||
| P/OCF | 11.59 | ||
| P/B | 2.63 | ||
| P/tB | 3.16 | ||
| EV/EBITDA | 5.52 |
EPS(TTM)2.08
EY5.18%
EPS(NY)2.32
Fwd EY5.79%
FCF(TTM)2.97
FCFY7.4%
OCF(TTM)3.46
OCFY8.63%
SpS34.2
BVpS15.26
TBVpS12.69
PEG (NY)N/A
PEG (5Y)1.72
Graham Number26.72
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.06% | ||
| ROE | 13.65% | ||
| ROCE | 15.78% | ||
| ROIC | 11.38% | ||
| ROICexc | 28.14% | ||
| ROICexgc | 41.95% | ||
| OM | 8.9% | ||
| PM (TTM) | 6.09% | ||
| GM | 99.93% | ||
| FCFM | 8.69% |
ROA(3y)7.25%
ROA(5y)6.8%
ROE(3y)13.74%
ROE(5y)12.58%
ROIC(3y)12.21%
ROIC(5y)11.57%
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)16.96%
ROCE(5y)16.06%
ROICexgc growth 3YN/A
ROICexgc growth 5Y9.54%
ROICexc growth 3YN/A
ROICexc growth 5Y6.91%
OM growth 3Y-3.33%
OM growth 5Y-0.03%
PM growth 3Y-0.09%
PM growth 5Y1.44%
GM growth 3Y0%
GM growth 5Y0%
F-Score7
Asset Turnover1.16
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.08 | ||
| Debt/FCF | 0.57 | ||
| Debt/EBITDA | 0.32 | ||
| Cap/Depr | 66.65% | ||
| Cap/Sales | 1.44% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 91.59% | ||
| Profit Quality | 142.65% | ||
| Current Ratio | 2.31 | ||
| Quick Ratio | 2.31 | ||
| Altman-Z | 4.44 |
F-Score7
WACC14.67%
ROIC/WACC0.78
Cap/Depr(3y)79.83%
Cap/Depr(5y)65.86%
Cap/Sales(3y)1.84%
Cap/Sales(5y)1.6%
Profit Quality(3y)115.8%
Profit Quality(5y)139.08%
High Growth Momentum
Growth
EPS 1Y (TTM)4.44%
EPS 3Y11.55%
EPS 5Y11.23%
EPS Q2Q%-7.43%
EPS Next Y0%
EPS Next 2Y4.65%
EPS Next 3Y8.74%
EPS Next 5Y8.04%
Revenue 1Y (TTM)7.39%
Revenue growth 3Y11.8%
Revenue growth 5Y9.7%
Sales Q2Q%5.42%
Revenue Next Year6.74%
Revenue Next 2Y6.12%
Revenue Next 3Y6.07%
Revenue Next 5Y5.57%
EBIT growth 1Y0.63%
EBIT growth 3Y8.08%
EBIT growth 5Y9.67%
EBIT Next Year17.11%
EBIT Next 3Y14.47%
EBIT Next 5Y11.67%
FCF growth 1Y13.36%
FCF growth 3Y7.7%
FCF growth 5Y6.25%
OCF growth 1Y11.51%
OCF growth 3Y9.37%
OCF growth 5Y6.59%
NEURONES / NRO.PA FAQ
What is the fundamental rating for NRO stock?
ChartMill assigns a fundamental rating of 6 / 10 to NRO.PA.
What is the valuation status for NRO stock?
ChartMill assigns a valuation rating of 4 / 10 to NEURONES (NRO.PA). This can be considered as Fairly Valued.
Can you provide the profitability details for NEURONES?
NEURONES (NRO.PA) has a profitability rating of 6 / 10.
How financially healthy is NEURONES?
The financial health rating of NEURONES (NRO.PA) is 9 / 10.
Can you provide the expected EPS growth for NRO stock?
The Earnings per Share (EPS) of NEURONES (NRO.PA) is expected to decline by 0% in the next year.